4JWR | Co-crystal structure of MDM2 with inhibitor {(2S,5R,6S)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2S)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid | date | 2013-03-27 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Shaffer, P.L. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.35 | ||||||||||||
ligand | 1MY | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Rational Design and Binding Mode Duality of MDM2-p53 Inhibitors., Gonzalez-Lopez de Turiso F, Sun D, Rew Y, Bartberger MD, Beck HP, Canon J, Chen A, Chow D, Correll TL, Huang X, Julian LD, Kayser F, Lo MC, Long AM, McMinn D, Oliner JD, Osgood T, Powers JP, Saiki AY, Schneider S, Shaffer P, Xiao SH, Yakowec P, Yan X, Ye Q, Yu D, Zhao X, Zhou J, Medina JC, Olson SH, J Med Chem. 2013 Apr 18. PMID:23597064 |
Data retrieval |
View 4JWR in 3D |
Visual 3D analysis of 4JWR |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4JWR |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |